Bill

Bill > A01462


NY A01462

NY A01462
Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients.


summary

Introduced
01/09/2025
In Committee
01/09/2025
Crossed Over
Passed
Dead

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT to amend the insurance law, in relation to establishing a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients

AI Summary

This bill establishes a mandatory five-business-day response window for private insurers and Medicaid when physicians submit pre-authorization claims for oncology patients' testing or treatments. Specifically, the legislation requires insurers to make a decision and notify the physician within five business days of receiving a pre-authorization claim. If an insurer fails to respond within this timeframe, the physician is automatically authorized to proceed with the recommended lifesaving testing, treatment, or procedure, and the insurer will be financially responsible for covering the cost of care. The bill aims to expedite critical medical care for cancer patients by creating a clear timeline for insurance approval and preventing potential delays that could negatively impact patient outcomes. The law would take effect immediately upon passage, applying to both private insurance companies and Medicaid in New York State.

Committee Categories

Business and Industry

Sponsors (4)

Last Action

referred to insurance (on 01/09/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...